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Abstract The appearance of phosphatidylserine (PS) on the
outer surface of red cells is an important signal for their uptake
by macrophages. We report for the first time that procaspase 3
present in the anucleated mature human erythrocyte is activated
under oxidative stress induced by t-butylhydroperoxide leading
to impairment of the aminophospholipid translocase, PS
externalization and increased erythrophagocytosis. This is the
first report linking caspase 3 activation to inhibition of flippase
activity and uptake of red cells by macrophages. ß 2002 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Normal circulating blood cells exhibit an asymmetric dis-
tribution of phospholipids in the membrane where phospha-
tidylserine (PS) and phosphatidylethanolamine (PE) reside in
the inner lea£et and phosphatidylcholine (PC) and sphingo-
myelin are enriched in the outer lea£et [1]. While asymmetry is
the rule for normal blood cells, loss of asymmetry is associ-
ated with pathologic phenomena in blood cells [2]. The ATP-
dependent aminophospholipid translocase transports PS and,
to a lesser extent, PE from the outer to the inner lea£et of the
plasma membrane against the concentration gradient, thereby
compensating for any escape of PS or PE to the outer lea£et
[3^5]. In contrast to the translocase, calcium-dependent bidi-
rectional movement of phospholipids across the membrane,
termed scrambling, shows no phospholipid speci¢city [6^8].
PS externalization has been linked to the anemia associated
with the human thalassemias [9,10] and with hyperglycemia
[11]. It has also been suggested that aminophospholipid trans-
locase activity diminishes during in vivo and arti¢cial aging of
human erythrocytes as a consequence of oxidative stress [12].
Apoptosis is a mode of programmed cell death that is under
molecular control [13]. Senescence of erythrocytes and apo-
ptosis of nucleated cells share the feature of externalization of
PS. Caspases are aspartate-speci¢c cysteine proteinases that
exist as latent zymogens, but once activated by apoptotic sig-
nals, they promote apoptosis by speci¢c limited proteolysis of
key cellular substrates [14]. Caspase 3 is synthesized as a 32
kDa zymogen that is processed to mature 20/17 kDa and 12
kDa subunits by cleavage at Asp9, Asp28 and Asp175 [15,16].
We have asked the question whether caspase 3 is present in
erythrocytes and whether it is involved in the process of PS
externalization and erythrophagocytosis in oxidatively
stressed erythrocytes. Our results demonstrate that procaspase
3 is present in mature erythrocytes. We demonstrate for the
¢rst time in anucleated cells that the process of PS external-
ization under oxidative stress is dependent on the activation of
caspase 3 which is associated with impairment of aminophos-
pholipid £ippase activity.
2. Materials and methods
2.1. Materials
The caspase 3 inhibitor Z-DEVD-FMK and acetyl-DEVD-p-nitro-
anilide (Ac-DEVD-pNA) were products of CN Biosciences (San Die-
go, CA, USA). Anti-caspase 3 antibody was from BD Pharmingen
(USA). The Annexin-£uos kit was from Roche Molecular Biochem-
icals (Mannheim, Germany); t-butylhydroperoxide (t-BHP) was a
product of Sigma Chemical Co. (St. Louis, MO, USA). 1-Palmitoyl-
2-[6-[7(nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-caproyl]-sn-glycerol-3-
phosphoserine (NBD-PS) was from Avanti Polar Lipids (Birmingham,
AL, USA).
2.2. Collection of blood and treatment with t-BHP
Blood was collected from normal healthy donors after informed
consent, erythrocytes were separated from whole blood on Ficoll,
washed in phosphate-bu¡ered saline (PBS), treated at 5% hematocrit
with t-BHP at 37‡C, aliquots were taken at di¡erent time intervals
and pelleted. The supernatant was collected to measure the degree of
hemolysis, by comparing the hemoglobin concentration in the super-
natant to that in the original cell suspension, by measuring the absor-
bance at 414 nm. The cells were washed three times in a ¢ve-fold
volume of PBS, and kept on ice for further analysis.
2.3. Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS^PAGE) and Western blot analysis of caspase 3
Erythrocytes were osmotically lysed in hypotonic solution and the
lysate was incubated overnight with rabbit anti-caspase 3 antibody at
4‡C. Protein A/G agarose was added and incubated for 1 h at room
temperature and the immunoprecipitate was washed, denatured and
separated by SDS^PAGE. Proteins were electrophoretically trans-
ferred to a nitrocellulose membrane and probed with anti-caspase 3
antibody followed by alkaline phosphatase-linked goat anti-rabbit
secondary antibody and ¢nally visualized using NBT/BCIP color de-
veloping reagent.
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2.4. Analysis of caspase 3 activity
DEVD-dependent protease activity was determined using Ac-
DEVD-pNA as substrate and the immunosorbent caspase 3 activity
assay kit from Roche Molecular Biochemicals. Brie£y, after treatment
of erythrocytes with t-BHP, lysates were prepared and caspase 3 was
captured from the lysate obtained from 100 Wl erythrocytes (5% he-
matocrit) in microplates coated with anti-caspase 3 monoclonal anti-
body. Following washing of the plates, Ac-DEVD-pNA was added
and the released pNA was determined spectrophotometrically at 405
nm. A pNA calibration curve was plotted from a pNA stock solution
and the caspase 3 activity was measured relative to this curve.
2.5. Erythrophagocytosis assay
Murine macrophage J774A.1 cells were maintained in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal bovine serum.
Phagocytosis assays were carried out as described by Pradhan et al.
[17]. Brie£y, erythrocytes (2U106 cells) were layered over macro-
phages (5U105 cells) on a coverslip and incubated at 37‡C for 1 h.
Non-adherent cells were removed by gentle washing with PBS and
surface-bound erythrocytes were lysed by treatment with 140 mM
NH4Cl/17 mM Tris^HCl, pH 7.6 for 5 min. Cells were stained with
diaminobenzidine for staining erythrocytes, and counterstained with
Giemsa stain for staining macrophages. Phagocytosis was calculated
in terms of the percentage of macrophages that ingested one or more
erythrocytes. t-BHP treatment was done for 60 min at 37‡C prior to
erythrophagocytosis assays.
2.6. Preparation of liposomes
Liposomes composed of brain PS, egg PC and cholesterol (C) at a
molar ratio of 1:1:1 or of PC and C at a molar ratio of 2:1 were
prepared as described by Sambrano and Steinberg [18]. Lipids and
butylated hydroxytoluene (20 WM) were dried under a stream of nitro-
gen, rehydrated in 40 mM Tris^HCl/140 mM NaCl to a ¢nal total
lipid concentration of 1.5 mM, mixed by vortexing and subsequently
sonicated in a bath-type sonicator under a nitrogen stream until clear.
2.7. Determination of aminophospholipid translocase activity
Flippase activity was assessed by the extent of £uorescent phospho-
lipids retained in the plasma membrane after back-extraction with
bovine serum albumin (BSA) which extracts only those exogenously
added £uorescent phospholipids and not endogenous phospholipids
from the outer monolayer [19]. Brie£y, prior to labeling, erythrocytes
were incubated with 5 mM diisopropyl-£uorophosphate in order to
prevent degradation of NBD-PS. NBD-PS was added to a ¢nal con-
centration of 1 WM to erythrocytes, incubated on ice for 5 min in
bu¡er A containing 5 mM HEPES, pH 7.5, 14 mM NaCl, 5 mM
KCl, 1 mM Mg2 and 10 mM glucose. Cells were washed and resus-
pended in 2 ml of bu¡er A. 100 Wl aliquots were removed at di¡erent
times intervals and added to 1 ml of bu¡er A containing 1% fatty
acid-free BSA in order to remove NBD-PS present in the outer lea£et.
Fluorescence associated with the supernatant was measured in a spec-
tro£uorimeter (excitation wavelength: 472 nm, emission wavelength:
534 nm).
2.8. Labeling with annexin-£uos and £ow cytometric analysis
Labeling with annexin-£uos to detect PS exposure on red cells was
performed using the Annexin-£uos kit according to the manufactur-
er’s instructions. Data acquisition was performed on a Becton Dick-
inson FACS Calibur £ow cytometer and analysis was done with Cell
Quest software. 10 000 events per sample were acquired to ensure
adequate mean £uorescence levels. The percentage of annexin V-pos-
itive erythrocytes was determined from the £uorescence signal in ex-
cess of that obtained with a negative (unlabeled control), which was
run for each sample.
2.9. Statistical analysis
Data obtained from independent experiments are represented as
mean þ S.D. and were compared by Student’s t-test. Di¡erences
were considered signi¢cant at P6 0.05.
3. Results
3.1. Oxidative stress activates caspase 3 in human erythrocytes
Erythrocytes were treated with di¡erent concentrations of
t-BHP for di¡erent times. The appearance of the 20 kDa form
after t-BHP (3 mM) treatment in a time-dependent manner
was considered to be an index of activation of caspase 3 (Fig.
1A). Caspase activation was further con¢rmed by measuring
the cleavage of the caspase 3-speci¢c substrate Ac-DEVD-
pNA. After treatment of erythrocytes with 3 mM t-BHP for
60 min at 37‡C, caspase 3 was captured from lysates in micro-
titer plates coated with anti-caspase 3 antibody. A time-de-
pendent release of pNA was observed (Fig. 1B). DEVD-pNA-
hydrolyzing activity was maximal by 2 h. In contrast, lysate
from erythrocytes incubated at 37‡C in the absence of t-BHP
for 20 min did not show any DEVD-pNA-hydrolyzing activ-
ity.
3.2. PS externalization governs erythrophagocytosis in
t-BHP-stressed erythrocytes
t-BHP-induced stress resulted in an increase in phagocytosis
of erythrocytes compared to normal erythrocytes (Table 1).
This was largely dependent on the externalization of PS, since
coincubation of erythrocytes with PS vesicles led to a com-
petitive inhibition of erythrophagocytosis of t-BHP-stressed
Fig. 1. Caspase 3 activation by t-BHP treatment. Red blood cells
were treated with 3 mM t-BHP at 37‡C, harvested at di¡erent time
periods and lysed. A: Lysates were immunoprecipitated with anti-
caspase 3 antibody, and analyzed for caspase 3 by Western blotting
as described in Section 2. The panel is representative of three sepa-
rate experiments. B: Caspase 3 was captured from lysates (obtained
after treatment with 3 mM t-BHP for 60 min) on to microtiter
plates coated with anti-caspase 3 antibody. Ac-DEVD-pNA (100
WM) was added to each well and the release of pNA was measured
spectrophotometrically at 405 nm at the indicated times. Results
represent the mean of ¢ve sets of determinations þ S.D.
FEBS 25782 11-3-02
D. Mandal et al./FEBS Letters 513 (2002) 184^188 185
erythrocytes (Table 1) in a dose-dependent manner, whereas
PC vesicles (containing no PS) had no e¡ect.
3.3. t-BHP-mediated PS externalization
Annexin V binding to PS is a widely used index of PS
externalization. The percentage of cells binding annexin-£uos
was measured by £ow cytometry. In six separate determina-
tions, it was observed that red cells treated with 1 mM and
3 mM t-BHP for 60 min had 5 þ 0.5% and 60 þ 5%
(means þ S.D.) of the cells labeled with annexin-£uos respec-
tively. Untreated red cells had 6 0.5% of the population la-
beled with annexin-£uos after incubation in bu¡er.
3.4. Inhibition of caspase 3 with Z-DEVD-FMK blocks
PS externalization and erythrophagocytosis in
t-BHP-stressed erythrocytes
The involvement of caspase 3 in the process of phagocytosis
of red cells induced by t-BHP was supported by the observa-
tion that pretreatment of the erythrocytes with Z-DEVD-
FMK (in 25 mM HEPES, 150 mM NaCl, pH 7.2 for 3 h at
25‡C) led to a signi¢cant decrease of t-BHP-induced phago-
cytosis of red cells (Table 1). Maximum inhibition of eryth-
rophagocytosis was achieved when cells were pretreated with
the inhibitor at a concentration of 100 WM for 3 h prior to
oxidative stress. In harmony with this was the observation
that treatment with Z-DEVD-FMK under similar conditions
led to an approximately 50% decrease (from 60 þ 6% to
29 þ 3%, six determinations) of PS externalization as visual-
ized by £ow cytometry. Fig. 2 shows a representative £ow
cytometric analysis of PS externalization in red blood cells
treated with 3 mM t-BHP without and with pretreatment
with 100 WM Z-DEVD-FMK for 3 h.
3.5. Oxidative stress-induced impairment of aminophospholipid
translocase activity is dependent on caspase 3
The translocation of PS from the outer to the inner lea£et
was measured after loading cells with £uorescent NBD-PS. It
was observed that PS externalization in t-BHP-stressed red
cells correlated with an impairment of aminophospholipid
translocase activity (Fig. 3) which could be blocked when cells
were treated with Z-DEVD-FMK prior to treatment with
t-BHP suggesting that caspase 3 was involved in the process
of loss of PS asymmetry in oxidatively stressed red cells
through its ability to impair the activity of the aminophos-
pholipid translocase.
4. Discussion
Since apoptosis in nucleated cells and erythrocyte senes-
cence share the common feature of PS externalization, we
explored the probable presence of caspase(s) in mature human
erythrocytes and their involvement in disruption of erythro-
cyte PS asymmetry. Recent studies have demonstrated that
Table 1
Uptake of oxidatively stressed erythrocytes by macrophages
Group Positive macrophages (%)
Normal 7 þ 1
Normal+t-BHP (1 mM)a 15 þ 3
Normal+t-BHP (3 mM) 48 þ 6
Normal+t-BHP (3 mM)+PS (2 nmol) 30 þ 5
Normal+t-BHP (3 mM)+PS (4 nmol) 22 þ 5
Normal+t-BHP (3 mM)+PS (8 nmol) 12 þ 3
Normal+t-BHP (3 mM)+PS (16 nmol) 9 þ 2
Normal+t-BHP (3 mM)+PC (16 nmol) 45 þ 7
Normal+t-BHP (3 mM)+Z-DEVD-FMK (50 WM) 25 þ 5
Normal+t-BHP (3 mM)+Z-DEVD-FMK (100 WM) 15 þ 3
Results represent the mean þ S.D. of six separate determinations.
aTreatment with t-BHP was carried out at 37‡C for 60 min.
Fig. 2. FACS analysis of annexin-£uos-positive erythrocytes after
t-BHP treatment. A: Cells treated with 3 mM t-BHP. B: Cells pre-
incubated with 100 WM Z-DEVD-FMK followed by treatment with
3 mM t-BHP for 60 min. The relative number of cells found in the
region marked by M2 was de¢ned as the percentage of annexin-
£uos-positive red blood cells.
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anucleated cells such as platelets contain functional proapop-
totic caspases such as caspase 3 and 9 [20]. The results re-
ported here o¡er some potentially important insights into the
process of erythrophagocytosis of oxidatively stressed eryth-
rocytes. We observe that procaspase 3 present in the mature
human erythrocyte undergoes cleavage from the 32 kDa zym-
ogen to the 20 kDa active form in oxidatively stressed eryth-
rocytes. Caspase 3 activation was con¢rmed by measuring the
ability of lysates derived from t-BHP-treated red cells to
cleave the caspase 3 substrate Ac-DEVD-pNA. Incubation
of oxidatively stressed red cells with annexin-£uos followed
by £ow cytometry suggested that t-BHP-induced oxidative
stress to red cells leads to externalization of PS which could
be blocked in part by pretreatment with the caspase 3 inhib-
itor Z-DEVD-FMK. In the light of recent observations that
annexin V can also bind to membrane products of lipid per-
oxidation [21], the enhanced binding of annexin V to t-BHP-
stressed red cells could not, however, be attributed solely to
PS externalization. Nevertheless, the role of caspase 3-medi-
ated PS externalization in erythrophagocytosis was supported
by our observations that t-BHP-induced erythrophagocytosis
could be blocked by competition with PS-containing lipo-
somes or when red cells were incubated with the caspase 3
inhibitor Z-DEVD-FMK prior to treatment with t-BHP. We
further observed that loss of the asymmetric distribution of PS
was causally linked to impaired activity of the aminophospho-
lipid translocase. Loss of aminophospholipid translocase ac-
tivity could be blocked when red cells were incubated with the
caspase 3 inhibitor Z-DEVD-FMK prior to treatment with
t-BHP. We propose that caspase 3 activation plays a crucial
role in loss of PS asymmetry and erythrocyte phagocytosis
under oxidative stress. We envision a process wherein caspase
3 activation negatively regulates aminophospholipid translo-
case either through direct proteolytic cleavage of the amino-
phospholipid translocase or, more likely, through an indirect
modulatory role involving intermediate regulators of the £ip-
pase. However, the fact that neither t-BHP-induced erythro-
phagocytosis nor PS externalization could be completely re-
versed by Z-DEVD-FMK suggests that caspase-mediated loss
of aminophospholipid translocase activity is one of the fac-
tors, but not the only one governing these processes. This is
the ¢rst demonstration of the critical role of caspase 3 in
potentially regulating the life span of the circulating mature
human erythrocyte by impairing the activity of the amino-
phospholipid translocase.
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